Supreme court to hear Reglan mislabeling case

10:49 am

The Supreme Court will now see the Reglan lawsuit case in order to determine whether the drug companies will be sued for not providing proper warning of the the side effects of the drug.

The Supreme Court will be deciding if the law helped to approve the drug because the FDA did approve it to be on the market.

The U.S. appeals court decided that the drug company may face claims after a woman sued them for developing a neurological disorder after taking the drug. The woman claims that she was never warned of the side effects. Another side effect that is associated with the drug is tardive dyskinesia, which causes unusual muscle movements.

Leave a Reply

Your email address will not be published. Required fields are marked *